Renasant Bank’s Bristol-Myers Squibb BMY Stock Holding History

Renasant Bank’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-4,684	Closed	-$286K	–	151
2025 Q1	$286K	Sell	4,684 -216	-4%	-$12.6K	0.19%	124
2024 Q4	$277K	Buy	4,900 +72	+1%	+$4.02K	0.18%	131
2024 Q3	$250K	Buy	+4,828	New	+$226K	0.16%	144
2022 Q3	–	Sell	-5,366	Closed	-$413K	–	174
2022 Q2	$413K	Sell	5,366 -2,208	-29%	-$168K	0.34%	96
2022 Q1	$553K	Buy	7,574 +4,056	+115%	+$272K	0.37%	84
2021 Q4	$219K	Buy	+3,518	New	+$206K	0.15%	188
2021 Q1	–	Sell	-3,373	Closed	-$210K	–	183
2020 Q4	$210K	Buy	+3,373	New	+$207K	0.17%	176

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Renasant Bank's BMY Position: Q2 2025 in Review

Renasant Bank sold out of Bristol-Myers Squibb (BMY) in Q2 2025, closing a stake of 4,684 shares — an estimated $286K sold.

Renasant Bank first reported a position in BMY in Q4 2020 and held it in 7 quarters. The position peaked at $553K in Q1 2022. 2,292 funds tracked by Wall St. Rank hold BMY as of Q2 2025.

Renasant Bank reported no remaining Bristol-Myers Squibb position as of Q2 2025 after selling out during the quarter.
Renasant Bank sold 4,684 Bristol-Myers Squibb shares in Q2 2025, an estimated $286K.
Renasant Bank first reported a position in Bristol-Myers Squibb in Q4 2020 and held it in 7 quarters.
Renasant Bank's Bristol-Myers Squibb position peaked at $553K in Q1 2022.
2,292 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2025.

Based on Renasant Bank's 13F filing for Q2 2025, filed 8 Aug 2025.